⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL

Official Title: A Phase 1 First-in-human Dose-escalation and Dose-expansion Study of BMF-219, an Oral Covalent Menin Inhibitor, in Adult Patients With Acute Leukemia (AL), Diffuse Large B-cell Lymphoma (DLBCL), Multiple Myeloma (MM), and Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL)

Study ID: NCT05153330

Interventions

BMF-219

Study Description

Brief Summary: A Phase 1 first-in-human dose-escalation and dose-expansion study of BMF-219, an oral covalent menin inhibitor, in adult patients with AML, ALL (with KMT2A/ MLL1r, NPM1 mutations), DLBCL, MM, and CLL/SLL.

Detailed Description: A Phase 1 first-in-human dose-escalation and dose-expansion study of BMF-219, an oral covalent menin inhibitor, in adult patients with acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL) with mixed lineage leukemia 1-rearranged (KMT2A/ MLL1r), nucleophosmin 1 (NPM1), diffuse large b-cell lymphoma (DLBCL), multiple myeloma (MM), and chronic lymphocytic lymphoma (CLL)/ small lymphocytic lymphoma (SLL).

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

University of California, Irvine, Irvine, California, United States

University of Southern California Norris Cancer Center, Los Angeles, California, United States

UCLA Department of Medicine, Los Angeles, California, United States

UC Davis Comprehensive Cancer Center, Sacramento, California, United States

Stanford Cancer Center, Stanford, California, United States

Mayo Clinic, Jacksonville, Florida, United States

Mount Sinai Medical Center, Miami Beach, Florida, United States

Moffitt Cancer Center, Tampa, Florida, United States

Blood & Marrow Transplant Group of GA (Northside Hospital), Atlanta, Georgia, United States

Northwestern University, Chicago, Illinois, United States

Henry Ford Hospital, Detroit, Michigan, United States

University of Cincinnati Medical Center, Cincinnati, Ohio, United States

Cleveland Clinic Foundation, Cleveland, Ohio, United States

University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States

Vanderbilt University Medical Center, Nashville, Tennessee, United States

MD Anderson Cancer Center, Houston, Texas, United States

Virginia Cancer Specialists, Gainesville, Virginia, United States

Evangelismos General Hospital of Athens, Athens, , Greece

Alexandra General Hospital of Athens, Athens, , Greece

AOU Ospedali Riuniti Ancona, Ancona, , Italy

ASST Papa Giovanni XXIII Hospital Bergamo, Bergamo, , Italy

Istituto Europeo di Oncologia, Milano, , Italy

Instituto Clinico Humanitas, Milan, , Italy

IRCCS Ospedale San Raffaele, Programma di Ricerca Strategica su LLC, Milan, , Italy

Ospedale Santa Maria della Misericordia, Perugia, , Italy

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, , Italy

Amsterdam UMC, Amsterdam, , Netherlands

UMCG Groningen, Groningen, , Netherlands

Radboud University Medical Center, Nijmegen, , Netherlands

Erasmus University Medical Center Rotterdam, Rotterdam, , Netherlands

Hospital General de Albacete, Albacete, , Spain

Hospital Clinic de Barcelona, Barcelona, , Spain

Institut Catala d'Oncologia, Barcelona, , Spain

Hospital San Pedro de Alcántara, Cáceres, , Spain

Hospital Universitario de la Princesa, Madrid, , Spain

Hospital Universitario Fundación Jiménez Díaz, Madrid, , Spain

Hospital Universitario 12 de Octubre, Madrid, , Spain

Hospital Universitario Central de Asturias, Oviedo, , Spain

Hospital Universitario de Salamanca, Salamanca, , Spain

Hospital Universitario Virgen del Rocio, Sevilla, , Spain

Hospital Universitario y Politécnico La Fe, Valencia, , Spain

Contact Details

Name: Alex Cacovean, MD

Affiliation: Biomea Fusion Inc.

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: